IDH1 and glioblastoma: Interestingly, a recent study suggests that tumors with IDH1 mutations cannot consume glucose as well as cells with wt IDH1, [57], and thus we could speculate that IL-11 signaling and enhanced glutamine metabolism used for survival in secondary glioblastoma may be even more pronounced due to their reduced ability to consume glucose.